Title |
Bone Mineral Density Changes among HIV-Uninfected Young Adults in a Randomised Trial of Pre-Exposure Prophylaxis with Tenofovir-Emtricitabine or Placebo in Botswana
|
---|---|
Published in |
PLOS ONE, March 2014
|
DOI | 10.1371/journal.pone.0090111 |
Pubmed ID | |
Authors |
Michael Kasonde, Richard W. Niska, Charles Rose, Faith L. Henderson, Tebogo M. Segolodi, Kyle Turner, Dawn K. Smith, Michael C. Thigpen, Lynn A. Paxton |
Abstract |
Tenofovir-emtricitabine (TDF-FTC) pre-exposure prophylaxis (PrEP) has been found to be effective for prevention of HIV infection in several clinical trials. Two studies of TDF PrEP among men who have sex with men showed slight bone mineral density (BMD) loss. We investigated the effect of TDF and the interaction of TDF and hormonal contraception on BMD among HIV-uninfected African men and women. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 2% |
United Kingdom | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 168 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 35 | 20% |
Researcher | 21 | 12% |
Student > Bachelor | 19 | 11% |
Other | 14 | 8% |
Student > Ph. D. Student | 12 | 7% |
Other | 30 | 17% |
Unknown | 42 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 68 | 39% |
Social Sciences | 13 | 8% |
Nursing and Health Professions | 12 | 7% |
Agricultural and Biological Sciences | 6 | 3% |
Psychology | 5 | 3% |
Other | 19 | 11% |
Unknown | 50 | 29% |